L-Tryptophan
L-tryptophan is one of the nine essential amino acids — the body cannot synthesise it and must obtain it from dietary protein. Metabolically it is the precursor to 5-hydroxytryptophan (5-HTP), serotonin, and onward to melatonin. Sold in the UK as a food supplement at 200–1000 mg/day, often combined with lemon balm, chamomile, magnesium, B6, and niacin in stress and sleep-support formulas. NO UK food-supplement health claims are authorised for L-tryptophan itself; the B6 / niacin / magnesium components of complex formulas carry authorised nervous-system and fatigue- reduction wording. The 1989 EMS outbreak (contamination-related, not L-tryptophan toxicity itself) underpins the historical purity-grade emphasis in supplement labelling. Serotonin-syndrome interaction list is extensive — disclose to your prescriber if you take any antidepressant, MAOI, triptan, tramadol, or related serotonergic drug. Pregnancy: avoid supplemental forms.
Camden Medicals editorial · Last reviewed 4 May 2026 · Next review November 2026
- Cross-checked against
- NHS
- NICE
- BNF
- EFSA
- FSA
Camden's editorial team independently graded each health claim below on the strength of the published evidence — see the grade beside every condition.
- Class
- Amino acid
- Top use evidence
- Limited
On this page
What it is
L-tryptophan is one of the nine essential amino acids and the only one that human biology cannot synthesise from other amino- acid carbon skeletons. It is a large neutral amino acid with an indole side chain — the indole ring is the structural feature that places tryptophan in the same chemical family as serotonin, melatonin, indole-3-carbinol, and the indole-class alkaloids. Dietary sources are protein-rich foods broadly: turkey and chicken, dairy, eggs, oats, legumes, pumpkin seeds, soybeans, and tofu. The popular "turkey makes you sleepy" story is largely folklore — turkey is not unusually high in tryptophan compared with other meats and the post-meal sleepiness people attribute to it is more about meal-size carbohydrate metabolism than tryptophan content per se.
Metabolically, L-tryptophan has three principal fates: protein synthesis (its primary biological role), the kynurenine pathway (which generates niacin and a series of immunomodulatory metabolites — about 95% of dietary tryptophan that is not used for protein synthesis goes this way), and the serotonin pathway (the minor metabolic fate but the one of supplement interest: L-tryptophan → 5-hydroxytryptophan → serotonin → onward to melatonin). Supplement formulators interested in the serotonin / melatonin axis can use L-tryptophan as the upstream substrate or 5-HTP / griffonia as a downstream precursor that bypasses the rate-limiting tryptophan-hydroxylase step.
Commercial L-tryptophan is overwhelmingly produced by microbial fermentation, typically using engineered Escherichia coli or Corynebacterium glutamicum strains. Quality-grade considerations centre on (a) the fermentation strain, (b) downstream purification (chromatographic separation), and (c) contaminant testing — the 1989 EMS outbreak was traced to contaminants in a specific manufacturer's process, not to L-tryptophan itself, and modern purity-grade declarations on supplement CoAs reflect that historical lesson.
Regulatory note: L-tryptophan is lawful as a UK food supplement. There are NO EFSA-authorised UK food-supplement health claims for L-tryptophan under Regulation 1924/2006 (retained). UK marketing copy must avoid sleep-aid and antidepressant-class claim language. The B6 / niacin / magnesium components common in complex tryptophan formulas DO carry authorised claims for nervous-system function, psychological function, and reduction of tiredness and fatigue — those claim wordings can be invoked on PDP copy for those nutrient components specifically, not for tryptophan as such.
At a glance
- L-tryptophan is one of the nine essential amino acids and the upstream precursor for serotonin and melatonin biosynthesis. The metabolic route is L-tryptophan → 5-HTP → serotonin → N-acetylserotonin → melatonin.
- NO UK-authorised food-supplement health claims attach to L-tryptophan as a substance under Regulation 1924/2006 (retained). The B6 / niacin / magnesium components of typical sleep-and-stress complex formulas DO carry authorised nervous-system, psychological-function, and fatigue-reduction claim wording — those wordings can be invoked for those nutrient components only, never for tryptophan itself.
- The 1989 eosinophilia-myalgia syndrome (EMS) outbreak was traced to contaminated bacterially-fermented L-tryptophan from a single Japanese manufacturer (Showa Denko). Roughly 1500 cases and 38 deaths were recorded in the US. Modern manufacturing uses different fermentation strains and tighter purity controls; the contaminant — not L-tryptophan itself — was the likely cause. Quality-grade and contaminant testing on the CoA is the load-bearing transparency marker as a result.
- Serotonin-syndrome interaction list is extensive. Disclose use to your prescriber if you take any SSRI (sertraline, fluoxetine, citalopram, escitalopram, paroxetine), SNRI (venlafaxine, duloxetine), MAOI (phenelzine, tranylcypromine, selegiline), tricyclic (amitriptyline, nortriptyline), tramadol, pethidine, fentanyl, triptan (sumatriptan, rizatriptan), lithium, dextromethorphan (DXM), St John's Wort, or carbidopa. The interaction list mirrors griffonia / 5-HTP (Camden NB-412), to which L-tryptophan is the upstream precursor.
- Sleep-onset latency: a small number of older trials suggested 1000 mg L-tryptophan reduced sleep-onset latency in some adults with mild sleep complaints. Subsequent evidence has not consolidated this into a strong positive recommendation. NHS sleep guidance does not list L-tryptophan among first-line interventions; sleep-hygiene measures and CBT-I remain the evidence-led first steps.
- Pregnancy and breastfeeding: avoid supplemental forms. Maternal serotonin and melatonin biology is delicate, the historical EMS contaminant story still informs the precautionary stance, and dietary protein already delivers tryptophan in safer biological context.
What people use it for
Adults with occasional sleep-onset difficulty exploring options beyond NHS first-line sleep-hygiene advice
L-tryptophan is one of several nutrient-precursor options some adults explore for sleep onset. The published clinical-trial evidence is older and modest in effect size; NHS sleep guidance does not list it among first-line interventions and sleep-hygiene plus, where indicated, cognitive behavioural therapy for insomnia (CBT-I) remain the evidence-led starting points. UK supplement labels must stay descriptive of the precursor-amino-acid context. [1,2]
Some evidenceLimitedAdults considering complex stress and sleep formulas with magnesium, B6, niacin, and herbal extracts
Complex formulas that pair L-tryptophan with magnesium bisglycinate, B6, niacin, lemon balm, and chamomile can claim — for the magnesium / B6 / niacin components — authorised wording around nervous-system function, psychological function, and reduction of tiredness and fatigue. The L-tryptophan and herbal-extract components carry no authorised claim wording; they are present for the precursor-amino-acid and traditional-use rationales respectively. [3]
Some evidenceLimited
How it works
L-tryptophan crosses the blood-brain barrier via the large-neutral- amino-acid (LNAA) transporter, in competition with leucine, isoleucine, valine, phenylalanine, and tyrosine. Brain entry is therefore sensitive to the broader plasma amino-acid balance — a high-protein meal can paradoxically reduce brain tryptophan uptake by raising competing-LNAA concentrations, which is why older sleep-onset advice involved carbohydrate-rich rather than protein-rich evening intake (insulin lowers competing LNAAs and relatively raises plasma tryptophan).
Once in the brain, L-tryptophan is hydroxylated to 5-hydroxytryptophan by tryptophan hydroxylase (the rate-limiting enzyme), then decarboxylated to serotonin by aromatic-L-amino- acid decarboxylase. Serotonin in the pineal gland is N-acetylated and methylated to melatonin under circadian control. This metabolic route is the supplement-design rationale for sleep and mood positioning, but the translation from metabolic-precursor logic to clinical-outcome trials of consistent quality is the long-standing weak link — the steps are heavily regulated and saturating the upstream substrate does not necessarily translate into proportionate downstream serotonin / melatonin effect.
Common myths
Myth""Turkey makes you sleepy because of all the tryptophan.""
RealityTurkey is not unusually high in tryptophan compared with chicken, beef, fish, eggs, or cheese. The post-Christmas-dinner sleepiness people attribute to turkey is more about meal-size and carbohydrate-driven insulin response than tryptophan content. Dietary tryptophan from a single meal also competes with other large neutral amino acids for brain entry, blunting any direct serotonin-precursor effect.
Myth""L-tryptophan is a natural sleep aid.""
RealityNHS and NICE sleep guidance do not recognise L-tryptophan as a first-line sleep intervention. The trial evidence is older and the effect size modest. "Natural" framing is not a regulatory category and does not substitute for the clinical-outcome evidence base. UK food-supplement claim rules do not authorise sleep-aid wording for tryptophan. [2,1]
Myth""The 1989 EMS scare proved L-tryptophan is dangerous.""
RealityThe opposite, in fact. The contemporary investigation traced EMS to specific contaminants in one manufacturer's product rather than to L-tryptophan itself. The historical lesson is about amino-acid manufacturing purity, not about tryptophan toxicity. Modern L-tryptophan supplements with declared quality grade and contaminant testing are not the 1989 product. Saying "L-tryptophan caused EMS" without that nuance distorts the actual finding. [4]
Myth""L-tryptophan and 5-HTP are interchangeable.""
RealityThey are upstream and downstream points in the same pathway. L-tryptophan is an essential amino acid converted to 5-HTP by the rate-limiting enzyme tryptophan hydroxylase. 5-HTP bypasses that step. Practically, 5-HTP delivers more serotonin precursor per milligram, but L-tryptophan also routes into protein synthesis and the kynurenine pathway, while 5-HTP does not. Their drug-interaction profiles are essentially identical (serotonin syndrome list is the same), but the supplement-design implications differ. Camden sells griffonia / 5-HTP as NB-412 and the two should be discussed in family terms but never as direct substitutes.
Myth""Tryptophan with a high-protein meal will boost serotonin.""
RealityA high-protein meal can paradoxically lower brain tryptophan uptake — the competing large neutral amino acids (leucine, isoleucine, valine, phenylalanine, tyrosine) compete with tryptophan for the same blood-brain barrier transporter. Carbohydrate-rich evening intake actually relatively raises plasma tryptophan via insulin lowering of competing LNAAs. The biology is not the simple "more protein = more serotonin" story consumer marketing sometimes implies.
🔬 Camden’s evidence review
The research Camden reviewed, graded on its strength. This is our own appraisal — it sits beneath the official guidance above, never above it.
Sleep-onset latency
LimitedEvidencelimitedOlder trials (1970s–1980s) suggested 1000 mg of L-tryptophan taken before bed reduced sleep-onset latency in some adults with mild sleep complaints. The effect size was modest and subsequent evidence has not consolidated the finding into a strong positive recommendation. NICE insomnia guidance (CKS Insomnia, 2022) does not list L-tryptophan among recommended interventions; sleep-hygiene measures and CBT-I are the evidence-led first-line steps. UK supplement marketing must therefore stay descriptive rather than invoke sleep-aid claim wording. [2,5]
Mood and depressive symptoms
InsufficientEvidenceinsufficientMechanistic interest in L-tryptophan as a serotonin precursor is not the same as clinical-outcome evidence in mood disorders. Acute tryptophan depletion studies show that lowering tryptophan can transiently lower mood in vulnerable individuals; the converse — that supplemental tryptophan reliably improves mood — does not follow with the same evidence weight. NICE depression guidance (NG222, 2022) does not list L-tryptophan among recommended interventions. UK supplement marketing for mood positioning on tryptophan is editorially unsafe. [6]
Premenstrual symptoms
InsufficientEvidenceinsufficientLimited older trials explored L-tryptophan in premenstrual dysphoric disorder. Evidence is insufficient to support UK supplement positioning in this category and NHS / RCOG premenstrual-syndrome guidance does not list it. [7]
Eosinophilia-myalgia syndrome — historical safety story
StrongEvidencestrongThe 1989 EMS outbreak in the US affected roughly 1500 people with 38 deaths. Investigation traced the cases to contaminated bacterially-fermented L-tryptophan from a single Japanese manufacturer (Showa Denko); the suspected contaminants ("peak E" / 1,1''-ethylidenebis-L-tryptophan and related impurities) were associated with a change in the manufacturer''s purification process. Modern L-tryptophan manufacturing uses different fermentation strains and tighter purification; the historical lesson is that contamination of amino-acid supplements is the relevant safety axis, not L-tryptophan toxicity itself. Quality-grade and contaminant testing on the CoA is the load-bearing transparency marker. [4]
Safety
Pregnancy and breastfeeding
Avoid supplemental L-tryptophan in pregnancy. Maternal serotonin and melatonin biology is delicate and the safety dataset on supplemental tryptophan in pregnancy is sparse. Dietary tryptophan from a varied protein intake is the appropriate context — concentrated supplement doses are not.
Avoid supplemental L-tryptophan during breastfeeding. Tryptophan and its metabolites cross into breast milk and the safety dataset on infant exposure to supplemental-grade maternal intake is absent.
Talk to your GP, midwife, or pharmacist before starting any supplement during pregnancy or breastfeeding.
Contraindications
- Concurrent use of MAOI antidepressants (phenelzine, tranylcypromine, isocarboxazid, selegiline, rasagiline) — risk of serotonin syndrome.
- Concurrent use of SSRIs, SNRIs, tricyclic antidepressants, tramadol, triptans, lithium, dextromethorphan, St John's Wort, or pethidine — serotonin-syndrome risk; do not combine without explicit prescriber sign-off.
- Carcinoid tumour or untreated phaeochromocytoma — serotonin-pathway activity is contraindicated.
- Active liver disease — kynurenine-pathway metabolism is hepatic; specialist advice needed.
Drug interactions
- SSRIs (sertraline, fluoxetine, citalopram, escitalopram, paroxetine), SNRIs (venlafaxine, duloxetine, desvenlafaxine), MAOIs (phenelzine, tranylcypromine, selegiline), tricyclics (amitriptyline, nortriptyline), tramadol, pethidine, fentanyl, triptans (sumatriptan, rizatriptan, zolmitriptan), lithium, dextromethorphan (DXM), St John's Wort, carbidopa: combined serotonergic activity raises the risk of serotonin syndrome — agitation, hyperreflexia, hyperthermia, tremor, autonomic instability. Do not combine without explicit prescriber agreement.
- Sedative medications (benzodiazepines, Z-drugs, opioids, sedating antihistamines): additive sedation; reduce starting dose and avoid driving / operating machinery until response known.
- Levodopa (Parkinson's disease therapy): peripheral conversion of L-tryptophan to 5-HTP in the presence of high-dose carbidopa-levodopa is a complex interaction; specialist advice.
- Benzodiazepines and other CNS depressants: additive drowsiness; not a contraindication but discuss with prescriber.
This is not an exhaustive list. Always tell your prescriber and pharmacist about every supplement you take.
Common side effects
- Mild gastrointestinal upset (nausea, heartburn) at higher per-day doses.
- Daytime drowsiness when taken at evening doses, persisting into the next morning in some users.
Rare side effects
- Headache and dizziness at the upper end of the published dose range.
- Eosinophilia-myalgia syndrome — historically associated with contaminated 1989-era L-tryptophan from a single manufacturer; not a contemporary risk with declared-quality material but the historical lesson informs the purity-grade emphasis.
- Serotonin syndrome (agitation, hyperreflexia, hyperthermia, tremor, diaphoresis) when combined with serotonergic drugs — see drug interactions.
How to take it
- Timing
- Take 30–60 minutes before bed if used for sleep-onset purpose. Take with a small carbohydrate-rich snack rather than with a high-protein meal — the LNAA-transporter biology means high-protein co-intake reduces brain entry. Avoid if you have eaten a large protein meal in the prior hour.
How to spot quality
Look for
- USP-grade L-tryptophan declared on the CoA. The historical lesson from the 1989 EMS outbreak is that contamination of bacterially-fermented amino acids is the relevant safety axis; modern declared-grade material with chromatographic-purity certification is the standard.
- Fermentation strain disclosure where available (Escherichia coli or Corynebacterium glutamicum are the typical commercial strains; the strain itself is not the safety axis but disclosure signals manufacturer transparency).
- Contaminant panel on the CoA — particularly chromatographic-purity figures and any "EBT" / "peak E" / "peak 200" / "peak X" indicator panels (the historical contaminant family).
- When sold in complex formulas with magnesium, B6, niacin, and herbal extracts, each declared component should appear with its own dose, not bundled into a proprietary blend with undeclared individual amounts. Authorised health-claim wording for B6 / niacin / magnesium requires per-serving dose to meet specified thresholds.
- Lemon balm (Melissa officinalis) and chamomile (Matricaria recutita) extracts in complex formulas should appear with extract ratio (e.g. "4:1 extract equivalent to 500 mg dry herb") declared, not just final extract milligrams.
Red flags
- Generic "L-Tryptophan Xmg" with no manufacturing-grade declaration, no fermentation-strain disclosure, and no contaminant panel on the CoA.
- Sleep-aid, antidepressant-class, anxiolytic, or "natural mood booster" marketing language not authorised under UK Regulation 1924/2006 (none exist for tryptophan).
- Per-day dose recommendations above 1000 mg without explicit reference to the published trial-dose range and absence of safety-trial data above that level.
- Combination with high-dose 5-HTP / griffonia in the same product or stack — the two are upstream-and-downstream in the same pathway; combining them risks compounding serotonergic activity without commensurate evidence of benefit.
- Absence of serotonin-syndrome interaction warnings on the label or PDP for SSRIs, SNRIs, MAOIs, tramadol, triptans, lithium, DXM, and St John's Wort.
Commonly combined with
Other ingredients that share a biological pathway, cofactor relationship, or evidence-backed protocol with this one. Mechanisms below cite primary physiology — not folk pairing. Doses are literature ranges, not recommendations. Talk to your pharmacist or GP before changing your stack, especially if you take prescription medication.
Griffonia (5-HTP source)
Limited evidenceSerotonin-precursor cluster — l-tryptophan upstream of 5-HTP (Griffonia simplicifolia seed yields 5-HTP). Use one or the other, NOT both — additive serotonergic load.
L-tryptophan → 5-HTP (Griffonia source) → serotonin → melatonin. Stacking both upstream and downstream substrates is additive and risks serotonin syndrome on top of any prescribed serotonergic medication.
Evidence: Camden griffonia NB-412 covers serotonin-syndrome list.
Doses studied: EITHER 500-1000 mg l-tryptophan OR 100-200 mg 5-HTP evening — not both.
Found in Camden: Purifera™ 5HTP from Griffonia Seed 90 Capsules
Magnesium
Limited evidenceSleep-cluster pairing — magnesium relaxation + l-tryptophan serotonin precursor.
Magnesium GABA / NMDA modulation + neuromuscular relaxation; l-tryptophan serotonin / melatonin substrate. Mechanism complementary.
Evidence: UK Article 13.1 magnesium psychological-function claim. [3]
Doses studied: 500-1000 mg l-tryptophan + 200-400 mg magnesium glycinate evening.
Found in Camden: Aurifera™ Magnesium Complex 120 Capsules
Vitamin B6
Limited evidenceCofactor cluster — B6 (pyridoxal-5-phosphate) is the cofactor for aromatic L-amino acid decarboxylase that converts 5-HTP to serotonin.
B6 is the cofactor that l-tryptophan → 5-HTP → serotonin pathway requires at the AADC step. Adequate B6 supports flux through the pathway. UK Article 13.1 B6 psychological-function and nervous-system claims.
Evidence: UK Article 13.1 B6 claims authorised. [3]
Doses studied: 500-1000 mg l-tryptophan + 1.4-10 mg B6 evening.
Tart Cherry (Montmorency)
Limited evidenceSleep-cluster pairing — l-tryptophan upstream serotonin / melatonin substrate + tart cherry direct melatonin source.
L-tryptophan synthesises melatonin endogenously; tart-cherry (Montmorency) delivers small amounts of melatonin directly. Mechanism complementary on the same downstream pathway.
Evidence: Camden tart-cherry covers cluster.
Doses studied: 500-1000 mg l-tryptophan + 1500 mg tart-cherry concentrate evening.
L-Theanine
Limited evidenceSleep-cluster pairing — l-theanine glutamatergic calm + l-tryptophan serotonin / melatonin precursor.
L-theanine alpha-wave calm signal + l-tryptophan upstream serotonin / melatonin synthesis substrate. Mechanism complementary across calm + sleep-onset axes.
Evidence: Camden l-tryptophan covers cluster.
Doses studied: 100-200 mg l-theanine + 500-1000 mg l-tryptophan evening.
Melatonin (Topical, skin-antioxidant context)
Limited evidenceSystemic precursor pathway — l-tryptophan → 5-HTP → serotonin → melatonin.
L-tryptophan is the upstream amino-acid precursor for endogenous melatonin synthesis (pineal + skin melatoninergic systems). Topical melatonin supplements local skin pool. Different contexts; both feed the melatoninergic system.
Evidence: Mechanism well-established; combination not directly trialled in skin context.
Doses studied: Topical melatonin 0.5-1% PM + oral l-tryptophan 500-1000 mg PM (Camden l-tryptophan covers the serotonin-syndrome warning list).